NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Dr. Eric G. Carter
King Appoints Chief Science Officer
King Pharmaceuticals, Bristol, Tenn., an integrated branded pharmaceutical company, has appointed Eric G. Carter, M.D., Ph.D., as chief science officer. Dr. Carter oversees King’s R&D, regulatory, and medical-affairs activities. Most recently, Dr. Carter served as VP and global head, clinical development and medical affairs, gastroenterology, and R&D for GlaxoSmithKline. After earning a bachelor’s degree in biochemistry from the University of London, Dr. Carter received his M.D. from the University of Miami, and Ph.D. from the University of Cambridge. Dr. Joseph DaBronzo Dr. Antonia LoPresti-Solis Nicole Merlo Dr. Mabel Lam Tse Kim Van iderstine Bing Yuan Eisai Announces New Hires and Job Changes Eisai, a U.S. pharmaceutical subsidiary of Eisai Co., has announced several new hires and promotions. Eisai, Teaneck, N.J., is a research-based human healthcare company that discovers, develops, and markets products in more than 30 countries. The company has appointed Joseph DaBronzo, Pharm.D., J.D., director, scientific and professional education. Dr. DaBronzo is responsible for leadership of the medical science liaison teams and chairs committees for the scientific review of Eisai grants for continuing medical education and independent investigator initiatives. Dr. DaBronzo has more than 15 years of pharmaceutical experience, having worked most recently with Sanofi Pasteur and Purdue Pharma. He holds a doctor of pharmacy degree from the State University of New York and juris doctor from Pace University. Antonia LoPresti-Solis, M.D., has been promoted to senior medical director, medical services. Dr. LoPresti-Solis is responsible for leading the medical safety team in providing for the review and assessment of evolving safety information for all products assigned to the U.S. General Safety Office. Dr. LoPresti-Solis completed her undergraduate degree in biology at St. Peter’s College in New Jersey and obtained her medical degree from St. George’s University School of Medicine. She is board certified in internal medicine and infectious disease. Among other promotions, Nicole Merlo has been promoted to product manager; Mabel Lam Tse, Pharm.D., has been promoted to senior drug information manager from drug information manager; and Kim Van Iderstine has been promoted to product manager from associate product manager. Bing Yuan has been promoted to senior manager, global medical and marketing services, from marketing manager, new products. Jamie Harrell Mark Stanton MedImmune Expands Commercial Organization MedImmune, Gaithersburg, Md., which focuses on the areas of infectious diseases, cancer, and inflammatory diseases, has added to its commercial management organization. Jamie Harrell has been appointed VP, infectious disease marketing, and Mark Stanton as VP, managed markets. The addition of Mr. Harrell and Mr. Stanton builds on MedImmune’s commercial leadership expansion. Mr. Harrell is responsible for leading the strategic direction of marketing activities for Synagis as well as the commercialization of MedImmune’s next-generation monoclonal antibody for RSV. Before joining MedImmune, Mr. Harrell was senior director at Centocor. He holds a bachelor’s degree in administration with a double major in marketing and economics from Samford University. Mr. Stanton is leveraging his 12 years of managed-care experience to build and lead MedImmune’s integrated strategy to support all products in the managed-care market. His previous position was at Endo Pharmaceuticals. He holds a bachelor’s degree in business administration from Castleton State College. Greg Irace Tim Rothwell Sanofi-Aventis Adds Staff Sanofi-Aventis, Bridgewater, N.J., a worldwide pharmaceutical company, has promoted Greg Irace to president and CEO of U.S. pharmaceutical operations from chief financial officer and senior VP, finance and administration. As president and CEO, Mr. Irace assumes executive leadership and management responsibility for the company’s pharmaceutical business in the United States. In other news, Tim Rothwell has been named chairman of U.S. pharmaceutical activities, which gives him direct responsibility for communications and government policy. He focuses broadly on group operations in the United States, including external Sanofi-Aventis efforts relating to communications and government policy aimed at projecting and protecting the company’s image and impact in the states. Dr. Mehmood Khan Takeda Global R&D Center Names President Takeda Global R&D Center, Deerfield, Ill., has appointed Mehmood Khan, M.D., as president. The organization develops new product candidates, conducts postmarketing clinical studies, and identifies and develops innovative life-cycle management approaches for marketed drugs. Formerly senior VP, medical and scientific affairs, for Takeda Pharmaceuticals North America, Dr. Khan brings more than 25 years of academic and clinical experience to the role. Before joining Takeda in 2003, he worked in the Mayo Clinic’s division of endocrinology. Dr. Khan earned his degree from the University of Liverpool Medical School, United Kingdom, and completed a fellowship in clinical endocrinology at the Department of Medicine, University of Minnesota. Bernard Poussot Wyeth Announces Executive Promotion Wyeth, Madison, N.J., a research-driven pharmaceutical and healthcare products company, has appointed Bernard Poussot, 55, president, chief operating officer, and vice chairman. Mr. Poussot remains responsible for Wyeth Pharmaceuticals and Wyeth R&D, as well as the Wyeth Consumer Healthcare and Fort Dodge Animal Health divisions of the company. Mr. Poussot has been at Wyeth for more than 20 years. In 2006, Mr. Poussot was promoted to president and vice chairman. Lori Queisser Brent Saunders Schering-Plough Makes Changes to Management Team Schering-Plough, Kenilworth, N.J., a global science-based healthcare company with leading prescription, consumer, and animal health products, has named Lori Queisser senior VP, global compliance and business practices. Ms. Queisser joins Schering-Plough from Eli Lilly. She holds a bachelor’s degree in science from Indiana University School of Business. Schering-Plough has promoted Brent Saunders to senior VP and president, consumer healthcare. Mr. Saunders is responsible for leading the U.S. and Canadian consumer healthcare business, and he works collaboratively with the global pharmaceutical business unit. Before joining Schering-Plough, Mr. Saunders was a partner at PricewaterhouseCoopers. He earned a J.D. from Temple University School of Law and an MBA from the Temple University School of Business and Management. He graduated with a B.A. in economics from the University of Pittsburgh. Dr. Bradley T. Sheares Reliant Names CEO Reliant Pharmaceuticals, Liberty Corner, N.J., has appointed Bradley T. Sheares, Ph.D., CEO. Reliant is a pharmaceutical company with integrated sales, marketing, and development expertise. Dr. Sheares, 49, joins the company from Merck. Dr. Sheares attended Fisk University, where he graduated Phi Beta Kappa and Summa Cum Laude with a degree in chemistry. He earned his Ph.D. in biochemistry from Purdue University. Biopharmaceutical POOL Robert I. Blum Dr. James H. Sabry Cytokinetics Announces Management Changes Cytokinetics, South San Francisco, Calif., has appointed Robert I. Blum CEO and elected James H. Sabry, M.D., Ph.D., to executive chairman of the board. Mr. Blum also is Cytokinetics’ president and with his additional responsibilities as the company’s CEO he continues to work closely with Dr. Sabry. Mr. Blum has been with Cytokinetics since 1998. He earned an MBA from Harvard Business School and holds B.A. degrees in human biology and economics from Stanford University. Daniel M. Bradbury Amylin Appoints CEO Amylin Pharmaceuticals, San Diego, a biopharmaceutical company committed to improving lives through the discovery, development, and commercialization of innovative medicines, has promoted Daniel M. Bradbury to president and CEO. Mr. Bradbury, 45, previously served as president and chief operating officer at Amylin. He received a bachelor of pharmacy from Nottingham University and a diploma in management studies from Harrow and Ealing Colleges of Higher Education. Dr. Edward C. Bradley VioQuest Appoints Chief Scientific Officer VioQuest Pharmaceuticals, a Basking Ridge, N.J.-based biopharmaceutical company, has appointed Edward C. Bradley, M.D., as chief scientific officer. VioQuest focuses on late preclinical and early-clinical stage therapies with mechanisms of action for oncology, viral, and autoimmune disorders Dr. Bradley joins VioQuest from Berlex Laboratories. Dr. Bradley is a diplomate of the American Board of Internal Medicine and is certified by the Board of Medical Oncology. He received his M.D. from Harvard Medical School. Dr. Paul Gesellchen Targanta Adds to Team Targanta Therapeutics, Cambridge, Mass., a privately held biopharmaceutical company developing and commercializing antibacterial drugs, has appointed Paul Gesellchen, Ph.D., VP, regulatory affairs. Dr. Gesellchen joins Targanta from Eli Lilly, where he most recently served as senior scientific director in the U.S. regulatory affairs department. Dr. Gesellchen obtained his Ph.D. in pharmaceutical chemistry from the University of Wisconsin-Madison and his B.S. in chemistry from the University of Nebraska-Lincoln. Jim Meyers Gilead Sciences Announces Senior Management Promotion Gilead Sciences, Foster City, Calif., has promoted Jim Meyers to senior VP, commercial operations, North America. Mr. Meyers has worked at Gilead, a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, for more than 10 years. He is a graduate of Boston College, holding a bachelor’s degree in economics. Howard W. Robin Nektar Names President and CEO Nektar Therapeutics, San Carlos, Calif., a biopharmaceutical company that develops and enables differentiated therapeutics with its drug delivery technologies, has appointed Howard W. Robin, 53, as the company’s president and CEO. Mr. Robin, with more than 25 years of experience managing clinical development and commercial operations, was formerly president and CEO at Sirna Therapeutics. Specialty POOL Dennis Bucceri Acusphere Hires Head, Regulatory Affairs Acusphere, Watertown, Mass., a specialty pharmaceutical company that develops drugs and improved formulations of existing drugs using its proprietary porous microsphere technology, has hired Dennis Bucceri as senior VP, regulatory affairs. Mr. Bucceri’s appointment strengthens the management team as the company prepares for the regulatory evaluation stage of Imagify, a cardiovascular drug for screening coronary artery disease, and evaluates development opportunities for other potential product candidates. He joins Acusphere from Genzyme. Alton Delane Bradley Pharmaceuticals Welcomes VP, Business Development Alton Delane has joined Bradley Pharmaceuticals, Fairfield, N.J., as VP, business development. Bradley is a specialty pharmaceutical company that markets to niche physician specialties. Mr. Delane is responsible for maximizing Bradley’s business development efforts, with a particular focus on acquisitions and licensing. Most recently, he served as VP, healthcare investment banking, for Raymond James. Mr. Delane holds an MBA from Harvard Business School and a B.S. in aerospace engineering from the United States Naval Academy. Dr. Dennis H. Giesing Urigen Appoints Product Development Director Urigen, Burlingame, Calif., a specialty pharmaceutical company focusing on urological disorders, has appointed Dennis H. Giesing, Ph.D., as director, product development. He is responsible for managing Urigen’s expanding drug development pipeline. Most recently, Dr. Giesing was CEO and cofounder of CepheidRX. Dr. Giesing holds a Ph.D. in biochemical pharmacology from the University of Missouri. Dr. Jeffrey M. Jonas New VP Joins Isis Isis, Carlsbad, Calif., a drug discovery and development company focused exclusively on the therapeutic target, RNA, has appointed Jeffrey M. Jonas, M.D., executive VP. Dr. Jonas leads clinical development, preclinical development, regulatory affairs, quality assurance, and compliance at Isis. He is broadly responsible for the entire pipeline, both partnered and unpartnered, and contributes to portfolio management. Before joining Isis Pharmaceuticals, Dr. Jonas was chief medical officer and executive VP at Forest Laboratories. Dr. Jonas received his M.D. from Harvard Medical School. Daniel S. Lynch Ivrea Pharmaceuticals Appoints President and CEO Ivrea Pharmaceuticals, Quincy, Mass., a privately held specialty pharmaceutical company focused on developing and commercializing novel treatments for dermatologic conditions, has appointed Daniel S. Lynch as president and CEO. Mr. Lynch has more than 20 years of healthcare leadership; before joining Ivrea he spent almost five years at ImClone Systems. Mr. Lynch holds an MBA from the Darden Graduate School of Business Administration at the University of Virginia and a B.A. in mathematics from Wesleyan University. James P. Shaffer New River Appoints VP, Sales and Marketing New River Pharmaceuticals, Radford, Va., a specialty pharmaceutical company developing novel pharmaceuticals, has appointed James P. Shaffer VP, sales and marketing. Operating from Raleigh, N.C., Mr. Shaffer is establishing a salesforce in preparation for the anticipated launch of Vyvanse. Mr. Shaffer comes to New River from Prestwick Pharmaceuticals. He holds an MBA in marketing from Ohio State University. Emerging POOL Dr. M. Michelle Berrey Dr. William T. Symonds New Appointments at Pharmasset Pharmasset, Princeton, N.J., a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing drugs to treat viral infections, has appointed M. Michelle Berrey, M.D., M.P.H., as chief medical officer, and William T. Symonds, Pharm.D., as VP, clinical pharmacology. Both Dr. Berrey and Dr. Symonds join Pharmasset from GlaxoSmithKline. Dr. Berrey’s experience includes the design, early development, medical governance, clinical strategy, and product life-cycle management for antiviral products. She received a master of public health from Emory University and her M.D. from the Medical College of Georgia. Dr. Symonds has clinical pharmacology experience in anti-infective and antiviral drug development, including international drug development and medical project management from Phases I to IV. He received his doctorate of pharmacy from Campbell University in North Carolina. Daniel Grau CombinatoRx Announces Senior Management Update CombinatoRx, Cambridge, Mass., which operates in the field of synergistic combination pharmaceuticals, has promoted Daniel Grau to the newly created position of chief operating officer. Mr. Grau is responsible for the areas of therapeutic program management, new products, strategic marketing, medical affairs, business development, alliance management, and informatics. He has been a key member of the management team, most recently as senior VP of commercial operations. He joined CombinatoRx in 2001. Mr. Grau earned his B.A. from Davidson College and holds M.A., M.A.R., and M.Phil. degrees from Yale University. He is the recipient of the Andrew J. Mellon Fellowship in the Humanities. Association POOL Anthony J. Costello Nextrials Founder to Steer SCDM Anthony J. Costello, cofounder and VP of product development and data services for clinical research software and services provider Nextrials, San Ramon, Calif., has been elected chairman of the Society for Clinical Data Management (SCDM) for 2007. SCDM is a nonprofit professional society founded to advance the discipline of clinical data management. Mr. Costello has been an active participant in the nonprofit professional organization for 10 years and has served on its board for two years, most recently as vice chairman and trustee. He has more than 15 years of experience in the development of software tools and data management techniques for the pharmaceutical industry. Robert L. Van nostrand Biotech Industry Veteran for NYBA Chairman The New York Biotechnology Association (NYBA) has appointed Robert L. Van Nostrand as its new chairman of the board of directors. He is senior VP and chief compliance officer at OSI Pharmaceuticals, and he brings more than 20 years of biotechnology management experience to his NYBA appointment. He serves a two-year term chairing the volunteer board of senior executives who represent New York’s leading companies, research centers, and professional service providers. Agency POOL Brian Adams Matt Means Kate Miller Patrick Ortlieb Blue Diesel Announces Promotions Blue Diesel, a multifaceted interactive communications and an inVentiv Health company based in Columbus, Ohio, has made several promotions. Brian Adams, formerly interactive art director, has been named associate creative director. He is responsible for providing strategic plans and vision to the brand team. Matt Means has been promoted to VP, creative director. Mr. Means is responsible for providing creative direction for day-to-day creative operations, new business development, and marketing plans. Before joining Blue Diesel, Mr. Means served as art director for Out of the Box Integrated Advertising. He holds a bachelor’s degree from Columbus College of Art and Design. Kate Miller has been promoted to senior copywriter from copywriter. In this position, she is responsible for writing copy for promotional materials, while managing a team of copywriters. Patrick Ortlieb has been promoted to senior account manager from account executive. He is responsible for overseeing creative brainstorming and implementing strategic tactics for assigned accounts. Michael Austin Chris Bedell Katie Beller Glenn Davis Thomas Doyle Sean Fenton Lisa Fox Donald Hanson Lisa Heaton Nathan Lemke Jennifer Louie Cory Myers Jennifer Oleski Lina Perez Nancy Pollack Scott Raidel Julie Ann Schipper Andy Spitzer Brian Sturtz Beth Wenstadt GSW Worldwide Announces Promotions and New Hires Healthcare advertising agency GSW Worldwide, Columbus, Ohio, an inVentiv Health company, has announced new hires and promotions in its New York and Columbus offices. Michael Austin has been promoted to group copy supervisor from copy supervisor. Chris Bedell has been promoted to senior account executive from account executive. Katie Beller has been promoted to VP, creative director. Ms. Beller had been an associate creative director. GSW has promoted Glenn Davis to VP, associate creative director, in its New York office. He is responsible for supervising creative teams on assigned accounts while leading the creative process for new business initiatives. Before joining GSW Worldwide, Mr. Davis served as art supervisor for Euro RSCG Life. Also in the New York office, Thomas Doyle has been hired as copy supervisor. Most recently, he served as copy supervisor for Grey Healthcare Group. Sean Fenton has been promoted to account executive with responsibilities for managing day-to-day workload and executing strategic objectives for assigned accounts. He had been an assistant account executive. Lisa Fox has been promoted to account director from account supervisor. Donald Hanson has been promoted to senior account executive from account executive. Lisa Heaton has been named associate director, marketing and business development. Formerly, she served in the role as manager, marketing and business development. Nathan Lemke has been named account director. He had been an account supervisor. Jennifer Louie has been named account director, formerly she was an account supervisor. Cory Myers has been promoted to art supervisor from senior art director. He collaborates with team members to implement print-design solutions. Jennifer Oleski has been promoted to account director from account supervisor. Lina Perez has been promoted to senior account executive from account executive. She is responsible for planning and executing tactics and managing the budget for assigned accounts. Nancy Pollack has been promoted to senior editor from editor. Scott Raidel has been promoted to senior medical strategist from medical strategist. GSW has named Julie Ann Schipper, VP, account director, in its New York office. Most recently, she was at FCB Healthcare. Andy Spitzer has been promoted to senior art director from art director. Brian Sturtz has been named senior account executive, a promotion from his role as account executive. Beth Wenstadt has been promoted to senior account executive from account executive. Norma Avitia Rick Beardsley Judy Doo Kate Julian Pacific Communications Expands Agency Team Pacific Communications, Costa Mesa, Calif., a full-service healthcare agency, has made a series of moves to bolster its facial aesthetics team. The agency has hired Norma Avitia as account supervisor, Ms. Avitia is responsible for the day-to-day account management for the professional promotion of Juvéderm. Before joining Pacific Communications, she worked at Rhea & Kaiser Marketing Communications. She holds a B.A., with honors in marketing communications/public relations from Columbia College. The agency has named Rick Beardsley as creative group supervisor on the agency’s Botox therapeutic and dermatology accounts, which gives him the responsibility for daily creative support and leadership and a primary role on the Tazorac and facial aesthetics accounts. Before joining Pacific Communications, Mr. Beardsley was an associate creative director for Corbett Accel Healthcare in New York. He has more than 20 years of experience working on multiple disease states. Judy Doo has been promoted to VP/management supervisor. She is responsible for overseeing the account teams for Allergan’s facial aesthetics portfolio, including Botox Cosmetic, Juvéderm, Cosmoderm/Cosmoplast, and physician-dispensed skin-care products. Before her promotion, Ms. Doo was the account group supervisor for Botox Cosmetic and Juvéderm. She has been with the agency eight years. Kate Julian has been promoted to account group supervisor, with responsibility for managing the account teams for Botox Cosmetic and dermal fillers, and overseeing the professional communication synergy among the facial injectable aesthetic products. Risa Bernstein Agency Cofounder Returns to Flashpoint Medica Flashpoint Medica, New York, a member of the Omnicom Group, celebrated the return of one of its founding partners, Risa Bernstein, who resumes her role as managing partner of the agency. Ms. Bernstein works with Cofounders Charlene Prounis and Helen Appelbaum. Jay Bolling Roska Names President Roska Healthcare Advertising, Montgomeryville, Pa., a full-service, strategically focused advertising and communications agency, has appointed Jay Bolling as president. Mr. Bolling leads the healthcare team in developing new direct-to-consumer and direct-to-patient campaigns for clients. Mr. Bolling has more than 20 years of experience in the pharmaceutical and healthcare markets and previously headed client services for Roska Healthcare. He also holds a bachelor’s degree in economics. Corey Case Craig Russell The Navicor Group Promotes Staff The Navicor Group, Columbus, Ohio, an inVentiv Health company and a full-service advertising agency that focuses exclusively on oncology and immunology, recently promoted Corey Case and Craig Russell. Mr. Case has been promoted to account director from account supervisor. He is responsible for team management, strategic client consultation, and financial management. Mr. Russell also has been promoted to account director from account supervisor. Similarly, he manages an account team and consults with assigned clients on strategic initiatives. Harold Corbran Jr. Draftfcb Names Executive VP Harold Corbran Jr., has joined Draftfcb HealthCare, New York, as executive VP and chief operating officer. Draftfcb HealthCare, part of Draftfcb, adapts and applies key insights and techniques from the behavioral sciences to brand-building communications. Mr. Corbran is responsible for the agency’s general operations. He is charged with identifying growth opportunities as well as developing and formalizing agency capabilities that benefit clients. Mr. Corbran most recently served at Euro RSCG Life Marketing. He holds a degree in psychology from St. John’s University. Sue DiGioia Ann Friedman-Ryan Jim Johnson Stonefly Announces Senior Management Promotions Stonefly Communications Group, Columbus, Ohio, an inVentiv Health company that is dedicated to channel-neutral healthcare solutions, has promoted Sue DiGioia to VP, associate creative director, with responsibility for overseeing day-to-day creative strategies, design, and production for her accounts. Before joining Stonefly, she served as art director at GSW Worldwide. The agency has named Ann Friedman-Ryan as executive VP, director of agency operations. Before joining Stonefly, she served as senior VP at Wunderman Worldwide. Jim Johnson has been hired as executive creative director. He is responsible for setting the creative vision, maintaining creative standards, and providing innovative campaign solutions. Mr. Johnson joins Stonefly Communications Group with more than 20 years of experience. Most recently, he served as senior VP at Grey Worldwide. David DiMatteo Jana Grimm Promotion and Hire at DMW DMW Worldwide, Wayne, Pa., a full-service direct response advertising agency, has appointed David DiMatteo as manager of media services. Mr. DiMatteo is responsible for all media in the support, development, and growth of the agency’s commercial division. Before joining DMW, Mr. DiMatteo worked at AIG Direct. Jana Grimm has been promoted to account executive. She joined the agency two years ago as marketing coordinator. Dr. Steve Dubansky Dr. Kim Irish Palio Communications Announces Promotions Palio Communications, Saratoga Springs, N.Y., a full-spectrum advertising and communications agency and an inVentiv health company has promoted Steve Dubansky, M.D., to senior VP, medical director, from VP, medical director. Dr. Dubansky has been with the agency since 2004. Kim Irish, Ph.D., has been promoted to VP, medical director, from associate medical director. Dr. Irish began at Palio in 2002. Steven Immergut Tonic Life Appoints Managing Director Tonic Life Communications, New York, an independent PR consultancy that specializes in supporting major brands and companies in the areas of life-science and lifestyle, has appointed Steven Immergut as managing director of the New York office. Mr. Immergut most recently served as senior VP with the GCI group. Rob Knoll HealthEd Hires Senior VP HealthEd, based in Clark, N.J., a leader in developing patient-education programs for pharmaceutical and healthcare marketers, has hired Rob Knoll as senior VP, operations. In this role, he facilitates greater efficiencies in HealthEd’s structure and operations, with an emphasis on maximizing quality and client satisfaction. Mr. Knoll is an industry veteran with 20 years of advertising and business operations experience in healthcare, financial, and business products marketplaces for both traditional and multimedia companies. Steve Lang HLG Adds Director, Client Services The Hal Lewis Group (HLG), Philadelphia, a branding agency focused on strategic marketing and advertising services for companies in the life-sciences, has appointed Steve Lang as director of client services. Mr. Lang has 27 years of healthcare and pharma experience working with Wyeth, Connaught-Elan, Wallace Labs, and McNeil. Katherine J. Maynard Promotion at Spectrum Science Communications Spectrum Science Communications, a health-only communications practice located in Washington, D.C., has promoted Katherine J. Maynard to executive VP, client services. Ms. Maynard’s new role calls for oversight of all client service, staffing, human resources, and administrative functions. Dr. Christopher Tobias Dudnyk Appoints Scientific and Strategic Services VP Dudnyk, Horsham, Pa., an independently owned, full-service branding, advertising, and marketing group, has appointed Christopher Tobias, Ph.D., senior VP, scientific and strategic services. Dr. Tobias leads the new business development efforts of the agency. Before joining Dudnyk, he was a senior scientific writer at Trinity Communications. Dr. Tobias received his B.S. in medical technology from Michigan State University, a master of science in physiology from Georgetown University, and a doctor of philosophy in neuroscience from Drexel University College of Medicine. Consulting POOL Dr. Jeffrey J. Freitag PharmaNet Consulting Appoints Senior VP PharmaNet Development Group, Princeton, N.J., a provider of drug development services, has announced that Jeffrey J. Freitag, M.D., FACP, has returned to its subsidiary PharmaNet as senior VP, PharmaNet Consulting. Dr. Freitag has worked in the pharmaceutical industry for more than 20 years in a variety of positions, most recently as VP, R&D, at Bone Care International. Dr. Freitag is board certified in both internal medicine and nephrology and has an academic, scientific, and clinical background. John Rackas The Benfield Group Hires VP, Healthcare Practice Healthcare consulting firm The Benfield Group, St. Louis, has hired John Rackas as VP, healthcare practice. Mr. Rackas, with more than 15 years of experience in the healthcare industry, assists pharmaceutical companies establish the value of their organizations and products with employers. Before joining The Benfield Group, Mr. Rackas worked for Sanofi-Aventis. CRO POOL Dr. James D. Esinhart Chiltern Appoints Global Head of Biometrics Chiltern International, Carlsbad, Calif., a global CRO, has appointed James D. Esinhart Ph.D., to the role of global head of biometrics. Dr. Esinhart joins Chiltern with more than 19 years of biopharmaceutical research experience, with the last 12 years spent in the CRO industry. Dr. Esinhart is based in Chiltern’s new Wilmington, N.C., office. He is responsible for overseeing Chiltern’s global biometrics, EDC, late phase, and IT divisions. Dr. Esinhart received his Ph.D. from the Medical College of Virginia. Dr. George Q. Mills Parexel Names VP, Medical Imaging Parexel International, a bio/pharmaceutical services organization, has appointed George Q. Mills, M.D., to the position of VP, medical imaging consulting, for Perceptive Informatics, Waltham, Mass., a Parexel company. Dr. Mills holds a medical degree from Creighton University in Omaha, Nebraska, an MBA from Pepperdine University, and a B.A. from the University of Nebraska. Dr. Chris W. Warner Kendle Hires Global Clinical Development Director Kendle, a global, full-service clinical research organization, has appointed Chris W. Warner, Ph.D., as director, global clinical development, North America. Dr. Warner is responsible for the direction of Phase I-III clinical development projects for the company’s biopharmaceutical customers. Previously at Salix Pharmaceuticals, he brings more than 30 years experience to Kendle, Cincinnati. Dr. Warner earned his Ph.D. in human anatomy from the University of Cincinnati, his M.S. in biological sciences from Wright State University, and his B.S. in biology from Ashland College. Medical-Education POOL Gabriel Bershadscky Dr. Todd Billeci Janis Cohen Jacqueline Zummo Expansion at Science & Medicine Science & Medicine, New York, a Publicis Healthcare Communications Group and a member of the Publicis Medical Education Group (PMEG), has expanded to support its client portfolio and medical education business. Gabriel Bershadscky joins the team as director, creative services, and is responsible for the overseeing the creative department. Todd Billeci, Ph.D., has been appointed to the newly created position of associate scientific director, HIV. Dr. Billeci was formerly with Discovery Chicago. Janis Cohen joins Science & Medicine as executive VP, managing director, from Global Edge. Jacqueline Zummo has been appointed to the new position of associate scientific director, and dermatology. She was formerly with MedAccess. Tighe Blazier Brian Haug Butch Hollenback Herb Marek MJH Announces Promotions MJH Associates, Plainsboro, N.J., the parent company of Intellisphere, HRA Research, and ArcMesa Educators, has promoted Tighe Blazier to president of ArcMesa Educators, an accredited provider of education courses servicing healthcare professionals. Mr. Blazier is responsible for overseeing the business operations of the medical education company. Brian Haug has been promoted to president, responsible for overseeing all business operations of Intellisphere. Butch Hollenback has been promoted to business manager of MJH. As business manager, Mr. Hollenback continues to oversee accounting and finance, and he expands his role to cover operational areas within human resources, facilities management, manufacturing, and circulation. Herb Marek has been promoted to president and chief operating officer of MJH. Marcy DeBiccari David Gottlieb Stephanie Robbins Steve Toman Selva Group Announces Moves The Selva Group, Saratoga Springs, N.Y., a full-service medical education and event management company, a division of Palio Communicaitons, and an inVentiv health company, has made a number of promotions. Marcy DeBiccari has been promoted to account supervisor/event services from account executive. Ms. DeBiccari has been a member of the company since 2005. David Gottlieb has been promoted to senior VP, account director, from VP, educational services. He joined the company in 2003. Stephanie Robbins has been promoted to account executive/event services from account coordinator. She has been a member of The Selva Group since 2005. Steve Toman has been promoted to VP, account director, from account director. He has been with company since 2004. Dawn Marie Dove Mary Krupinsky Laura Wuerth Staff Added at CRG The thought-leader focused medical education organization The Curry Rockefeller Group of Companies (CRG), Tarrytown, N.Y., has appointed Dawn Marie Dove as program manager in the CRG Connect division. Ms. Dove is a seven-year veteran in the medical education field, most recently serving as a manager with Novus Communications. Mary Krupinsky has been promoted to senior VP, client services. Ms. Krupinsky was previously VP, operations, of CRG Connect. In her new capacity, she increases her involvement in new business development and retains authority of CRG Connect. CRG has hired Laura Wuerth as director, account management. Ms. Wuerth has 15 years of experience in the pharmaceutical field, most recently with PPSI Communications. She is a graduate of The University of Scranton, where she earned her bachelor of science in biology. Kia Gray Indicia Hires Educational Program Manager Indicia Medical Education, a North Wales, Pa.-based medical-education company, has expanded its staff with the addition of Kia Gray, MPH, as educational program manager. In this managerial role, Ms. Gray is involved in all phases of program management, from liaison with faculty and accredited educational partners to a management of all activity logistics. In addition, she works closely with physician educators to develop timely, effective educational activities. She earned her B.A. in communications and health sciences from West Chester University and her MPH in public health from Drexel University. Service POOL Lloyd Baroody PharmaDesign Appoints Chief Operating Officer PharmaDesign, Warren, N.J., has appointed Lloyd Baroody as chief operating officer for the group. PharmaDesign manufactures products to optimize pharmaceutical brand performance while improving patient compliance, educating patients, and increasing their understanding of medical conditions, diseases, and treatment. He was formerly CEO of Clinsys and has 30 years of experience, mostly in the pharma industry. Mr. Baroody has an MBA from the Harvard Business School and a B.A. from McGill University in Montreal. Edward Barret Ronald Scalici Hire and Promotion at Group DCA Group DCA, Montclair, N.J., an online healthcare communications company that creates promotional, educational, and research programs for pharmaceutical companies, has hired Edward Barret and promoted Ronald Scalici as principals of the new C.U.E. Card Division. The C.U.E. Card, for which the division is named, is a portable, credit card-sized CD-ROM that makes it easy for patients to access interactive, educational content — both on the card and online. The two executives jointly head the new venture, which is primarily focused on patient adherence and education. Mr. Barret has more than 23 years of experience in business development and account management in the consumer packaged goods and retail industries. Before joining Group DCA, he was senior VP for SPAR Group. Mr. Barret earned his MBA in marketing management from Zicklin School of Business, Baruch College, The City University of New York, and received a B.A. in economics and advertising from Rutgers University. Mr. Scalici is an innovator in pharmaceutical e-marketing communications, and his active learning techniques have been engaging physicians for the last six years. Tim Callahan Dave Parker /alert Marketing Appoints Account Managers /alert Marketing, Rutherford, N.J., a provider of mail delivery systems for reaching healthcare professionals, has appointed Tim Callahan and Dave Parker as account managers. /alert Marketing is a division of Jobson Medical Information, Santa Clara, Calif. Mr. Callahan comes to /alert Marketing with more than six years of pharmaceutical industry sales experience. Most recently, he was an account executive at SuperNova Productions. Mr. Parker comes to /alert Marketing with more than eight years of industry-based experience. For the last seven years, Mr. Parker was an account supervisor with AbelsonTaylor. Brian Corvino Sarah Dobson PharmaStrat Announces Promotions PharmaStrat, Flemington, N.J., a provider of market research and consulting services in the pharmaceutical and biotech industries, has promoted Brian Corvino and Sarah Dobson. Mr. Corvino has been named partner, having previously been consulting director. In this new role, he is responsible for client consulting initiatives in areas that include international and domestic health policy strategy. He was previously employed at Janssen Pharmaceutica. He earned a B.A. in economics and political science and an honors on distinction competitive advantage in the pharmaceutical industry from Moravian College. Ms. Dobson has been promoted to manager of strategic services from senior analyst. Ms. Dobson’s responsibilities include managing all aspects of PharmaStrat’s strategic advisory initiatives, including complex advisory board series’ and focus groups. Ms. Dobson graduated Suma Cum Laude from Rutgers University with a B.A. in economics and political science. Fred Ewald Joann Flynn T. Greg Michael Lisa Montrone Marianne Nugent Duane Smulling Publicis Announces New Hires and Promotions Publicis Selling Solutions Group, a Publicis Healthcare Communications Group company based in Lawrenceville, N.J., has announced several new hires and promotions. The group offers innovative and strategic selling solutions to the pharmaceutical, biotech, and medical device industries through its companies. Fred Ewald has been hired as director, incentive compensation. His previous position was at McNeil Consumer and Specialty Pharmaceuticals. Joann Flynn has been hired as business development analyst at Publicis Selling Solutions. Before joining the company, Ms. Flynn was founder and president of Designs for Wellness. Publicis has appointed T. Greg Michael as senior VP, business development. Mr. Michael brings a broad range of pharmaceutical and sales leadership experience. He was previously with PDI. Lisa Montrone has been hired as senior director, project management and analytics. Before joining Publicis, Ms. Montrone served as a consultant in the pharmaceutical industry. Marianne Nugent has joined the company as director, Publicis Managed Markets Account Teams Operations. Ms. Nugent has been working as a consultant for Publicis. Duane Smulling has been hired as senior director, business development. Previously with PDI, Mr. Smulling has a strong background in the biopharmaceutical industry, information services, business development, and account management. Dr. John R. Haig MattsonJack Appoints VP, Marketing Research MattsonJack, part of Kantar Group, the information and consultancy division within WPP, St Louis, has appointed John R. Haig, Ph.D., VP, marketing research. MattsonJack focuses on three areas of core competency: business analytics, brand optimization, and corporate development services in the pharmaceutical and biotech markets. Dr. Haig brings 20 years of experience to MattsonJack’s marketing research practice. Before joining the company, he worked for TVG. Dr. Haig earned a Ph.D. in developmental psychology from the University of North Carolina at Chapel Hill. Laurie Lockwood Harris RG+A Appoints VP Roger Green and Associates (RG+A), New Hope, Pa., a provider of healthcare marketing research and insights, has appointed Laurie Lockwood Harris as executive VP and chief operating officer. Ms. Harris joins Roger Green and Associates (RG+A) from Synovate Healthcare (SHC), bringing more than 30 years of experience in marketing research. Technology POOL Rich Bishop Relsys International Appoints VP, Global Professional Services Relsys International, Irvine, Calif., a provider of software solutions for adverse event reporting, pharmacovigilance, and risk management for the pharmaceutical industry, has hired Rich Bishop as VP, global professional services. Before joining Relsys, Mr. Bishop spent 12 years at SAS Institute. He has more than 20 years of experience in technical software development, support, training, and management, with a majority of that time spent in the field working directly with clients. Mr. Bishop taught computer languages and systems architecture at Penn State University. Lisa Clune EduNeering Names Senior VP, Operations EduNeering, Princeton, N.J., a provider of knowledge management solutions, has named Lisa Clune senior VP, operations, and chief technology officer. Before her promotion, she served as EduNeering’s chief technology officer, directing the technology and project management resources of the company. In this new role, she is responsible for all of EduNeering’s client and professional services, contract execution, and technology delivery. Ms. Clune has extensive expertise in the integration of enterprise applications, including SAP, Siebel, and Oracle, a key growth area for the company. Before joining EduNeering, Ms. Clune served with General Electric Healthcare. Susan Rizzo ClinPhone Expands Presence in New England ClinPhone, with U.S. operations based in Princeton, N.J., and corporate headquarters in Nottingham, United Kingdom, a leader in clinical technology solutions, has appointed Susan Rizzo as associate director of operations in the company’s new office in Boston. Ms. Rizzo joined the company in 1999 and helped to establish the first ClinPhone office in Princeton, N.J. F Send your personnel announcements to email@example.com.